SZELA MARY T (CEO and President) purchased 4.1% of their position (30.49K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $125.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/23/2026ACC: 0001628280-26-010603
DirectorOfficer· CEO and President
Since Feb 2026
+30.49K
Net shares
Net buyer
$125.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
30.49K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30.49K
Price / share
$4.10
Trade value
$125K
% of position
4.1%
2/23/2026
742.80K→773.29K
Total
Net shares
+30.49K
Net value
$125K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | P · Purchase | +30.49K | $4.10 | $125K | 4.1% | 742.80K | 773.29K |
| Total | +30.49K | $125K | ||||||
Derivative Transactions0
No derivative transactions reported